Apalutamide is a nonsteroidal androgen receptor antagonist used as a pharmaceutical raw material for the manufacturing of medications indicated in castration-resistant prostate cancer. It selectively binds to the androgen receptor ligand-binding domain, blocking nuclear translocation and transcription of androgen receptor gene targets.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 956104-40-8
Apalutamide Dithio Impurity
Active pharmaceutical ingredient impurity
Apalutamide Di-(2-fluoro-N-methylbenzamide)
active pharmaceutical ingredient impurity
Apalutamide metabolite M2
active pharmaceutical ingredient metabolite
Methyl 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoate
research compound
Ranolazine
active pharmaceutical ingredient
Ranolazine dihydrochloride
active pharmaceutical ingredient
Fluindione
vitamin K antagonist anticoagulant
Delta9,11-Eplerenone
active pharmaceutical ingredient
4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide
HJBWBFZLDZWPHF-UHFFFAOYSA-N
CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F